Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhalable Nanoparticle-based Dry Powder Formulations for Respiratory Diseases: Challenges and Strategies for Translational Research
Ho Wan Chan, Stephanie Chow, Xinyue Zhang, et al.
AAPS PharmSciTech (2023) Vol. 24, Iss. 4
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Recent advances in nanoparticle applications in respiratory disorders: a review
Mohammad Ehsan Taghavizadeh Yazdi, Mohsen Qayoomian, Sima Beigoli, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 41
Nano-Formulations for Pulmonary Delivery: Past, Present, and Future Perspectives
Siyuan Peng, Wenhao Wang, Rui Zhang, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 161-161
Open Access | Times Cited: 17
A respiratory mucosal vaccine based on chitosan/aluminum adjuvant induces both mucosal and systemic immune responses
Ruitong Chen, Meifeng Nie, Yili Jiang, et al.
International Journal of Pharmaceutics (2025) Vol. 670, pp. 125168-125168
Closed Access | Times Cited: 2
Harnessing inhaled nanoparticles to overcome the pulmonary barrier for respiratory disease therapy
Zhaokui Jin, Qi Gao, Keke Wu, et al.
Advanced Drug Delivery Reviews (2023) Vol. 202, pp. 115111-115111
Closed Access | Times Cited: 34
Nano-based carriers for pulmonary drug delivery: A review on the available drug delivery applications and toxicity issues
Panoraia I. Siafaka, Ece Özcan Bülbül, Αndroulla N. Miliotou, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 92, pp. 105381-105381
Closed Access | Times Cited: 9
Inhalable paclitaxel nanoagglomerate dry powders for lung cancer chemotherapy: Design of experiments-guided development, characterization and in vitro evaluation
Ho Wan Chan, Xinyue Zhang, Stephanie Chow, et al.
International Journal of Pharmaceutics (2024) Vol. 653, pp. 123877-123877
Closed Access | Times Cited: 8
Nanoparticle-Based Drug Delivery Systems in Inhaled Therapy: Improving Respiratory Medicine
Elena Cojocaru, Ovidiu Rusalim Petriș, Cristian Cojocaru
Pharmaceuticals (2024) Vol. 17, Iss. 8, pp. 1059-1059
Open Access | Times Cited: 8
Current trends in inhaled pharmaceuticals: challenges and opportunities in respiratory infections treatment
Kiramat Ali Shah, Anam Razzaq, Amos Dormocara, et al.
Journal of Pharmaceutical Investigation (2025)
Closed Access | Times Cited: 1
Inhalable Nano Formulation of Cabazitaxel: A Comparative Study with Intravenous Route
Elif Kağa, Sadık Kağa, Korhan Altunbas, et al.
Macromolecular Bioscience (2025)
Open Access | Times Cited: 1
Role of Particle Size in Translational Research of Nanomedicines for Successful Drug Delivery: Discrepancies and Inadequacies
Ho Wan Chan, Stephanie Chow, Xinyue Zhang, et al.
Journal of Pharmaceutical Sciences (2023) Vol. 112, Iss. 9, pp. 2371-2384
Closed Access | Times Cited: 15
Biocompatible biodegradable polymeric nanocarriers in dry powder inhalers (DPIs) for pulmonary inhalation delivery
David Encinas-Basurto, Basanth Babu Eedara, Heidi M. Mansour
Journal of Pharmaceutical Investigation (2024) Vol. 54, Iss. 2, pp. 145-160
Closed Access | Times Cited: 5
Stabilized Extracellular Vesicle Formulations for Inhalable Dry Powder Development
Evalyne M. Jansen, Luke van der Koog, Robin A.B. Elferink, et al.
Small (2025)
Open Access
Inhalable pH-responsive core-shell nanocarriers with PEGylated chitosan/alginate layer-by-layer coating for sequential drug release in lung cancer therapy
Mariam Hossam Eldin, Reem K. Arafa, Osman Gamal, et al.
International Journal of Biological Macromolecules (2025), pp. 141851-141851
Closed Access
Novel inhalable nano-based/microparticles for enhanced sustained pulmonary delivery of remdesivir - a patient malleable treatment for coronaviruses infection: in vitro aerosolization, cytotoxicity assays and antiviral activity studies.
Shahinaze A. Fouad, Fady A. Malaak, Mahmoud H. Teaima, et al.
Journal of Drug Delivery Science and Technology (2024), pp. 106196-106196
Closed Access | Times Cited: 4
Inhaled dry powder of bedaquiline loaded nano-carrier for the treatment of multi-drug resistant tuberculosis
Priyank Patel, Rakeshkumar Parmar
Journal of Research in Pharmacy (2025) Vol. 29, Iss. 1, pp. 445-468
Open Access
Unlocking the potential of remdesivir: innovative approaches to drug delivery
Maie S. Taha, Ahsan R. Akram, Ghada A. Abdelbary
Drug Delivery and Translational Research (2025)
Open Access
Dry powder inhaler design and particle technology in enhancing Pulmonary drug deposition: challenges and future strategies
Nazrul Islam, Tan Suwandecha, Teerapol Srichana
DARU Journal of Pharmaceutical Sciences (2024)
Closed Access | Times Cited: 3
Lipid polymer hybrid nanoparticles against lung cancer and their application as inhalable formulation
Seyedeh Negin Kassaee, Derek J. Richard, Godwin A. Ayoko, et al.
Nanomedicine (2024) Vol. 19, Iss. 25, pp. 2113-2133
Closed Access | Times Cited: 3
Targeted delivery of the metastasis-specific tumour homing TMTP1 peptide to non-small-cell lung cancer (NSCLC) using inhalable hybrid nano-assemblies
Eupa Ray, Krishna Jadhav, Monika Kadian, et al.
Journal of Materials Chemistry B (2024) Vol. 12, Iss. 38, pp. 9740-9759
Closed Access | Times Cited: 3
Polyacrylic Acid: A Biocompatible and Biodegradable Polymer for Controlled Drug Delivery
Hossein Eslami, Mojtaba Ansari, Ahmad Darvishi, et al.
Polymer Science Series A (2023) Vol. 65, Iss. 6, pp. 702-713
Closed Access | Times Cited: 7
Novel Administration Routes, Delivery Vectors, and Application of Vaccines Based on Biotechnologies: A Review
Chung-I Rai, Tsu-Hsiang Kuo, Yuan‐Chuan Chen
Vaccines (2024) Vol. 12, Iss. 9, pp. 1002-1002
Open Access | Times Cited: 2
Novel strategies in systemic and local administration of therapeutic monoclonal antibodies
Monika Prašnikar, Maja Bjelošević Žiberna, Mirjam Gosenca Matjaž, et al.
International Journal of Pharmaceutics (2024) Vol. 667, pp. 124877-124877
Open Access | Times Cited: 2
Engineering Inhalable Therapeutic Particles: Conventional and Emerging Approaches
Aditi Negi, Shubham Nimbkar, J.A. Moses
Pharmaceutics (2023) Vol. 15, Iss. 12, pp. 2706-2706
Open Access | Times Cited: 5
Building respirable powder architectures: utilizing polysaccharides for precise control of particle morphology for enhanced pulmonary drug delivery
Kazunori Kadota, Hiromasa Uchiyama, Tero Kämäräinen, et al.
Expert Opinion on Drug Delivery (2024) Vol. 21, Iss. 6, pp. 945-963
Closed Access | Times Cited: 1
Inhalable dry powder nano-formulations: advancing lung disease therapy-a review
Faiza Naureen, Yasar Shah, Maqsood Ur Rehman, et al.
Frontiers in Nanotechnology (2024) Vol. 6
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top